RecruitingNot Applicable

CTFFR and Prediction of Non-Significant CAD Lesions

Iran250 participantsStarted 2024-01-01

Plain-language summary

In this prospective cohort study, 250 patients with suspected or known CAD and at least one intermediate coronary lesion (50-70% stenosis) who had a NiFFR value greater than 0.80 underwent coronary computed tomography angiography (CCTA) with NiFFR assessment. Patients were followed for one year to monitor for MACE

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients were enrolled if they had at least one intermediate coronary lesion (classified as 50-70% diameter stenosis on visual judgment) on CCTA and then underwent FFR testing Exclusion Criteria: * Patients having past coronary artery bypass graft surgery (CABG) * previous PCI in the target vascular * significant renal impairment define with eGFR \< 30 mL/min/1.73 m² * contrast allergy * poor image quality that prevented appropriate CCTA or CT-FFR analysis

What they're measuring

Number of patients with MACE

Timeframe: 1 year

Number of patients with bleeding

Timeframe: 1 year

Trial details

NCT IDNCT06979427

SponsorShiraz University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-01

Contact for this trial

javad UOM kojuri

09171115083 kojurij@yahoo.com

View on ClinicalTrials.gov More Chronic Coronary Syndrome trials